Skip to main content
main-content

Zeitschrift

Brain Tumor Pathology

Brain Tumor Pathology 1/2021

Ausgabe 1/2021

Inhaltsverzeichnis ( 11 Artikel )

05.01.2021 | Editorial | Ausgabe 1/2021

The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system

Takashi Komori

29.09.2020 | Original Article | Ausgabe 1/2021

H3 G34-mutant high-grade glioma

Ka Young Lim, Jae Kyung Won, Chul-Kee Park, Seung-Ki Kim, Seung Hong Choi, Taemin Kim, Hongseok Yun, Sung-Hye Park

08.09.2020 | Original Article | Ausgabe 1/2021

Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA)

Ghadeer Almuhaisen, Yazan Alhalaseh, Razan Mansour, Amer Abu-Shanab, Sura Al-Ghnimat, Maysa Al-Hussaini

28.09.2020 | Original Article | Ausgabe 1/2021

Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors

Keiichiro Kitahama, Shohei Iijima, Ayumi Sumiishi, Akimasa Hayashi, Kiyotaka Nagahama, Kuniaki Saito, Nobuyoshi Sasaki, Keiichi Kobayashi, Saki Shimizu, Motoo Nagane, Junji Shibahara

01.11.2020 | Original Article | Ausgabe 1/2021

EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations

Aruna Nambirajan, Agrima Sharma, Madhu Rajeshwari, Meher Tej Boorgula, Ramesh Doddamani, Ajay Garg, Vaishali Suri, Chitra Sarkar, Mehar Chand Sharma

27.09.2020 | Original Article | Ausgabe 1/2021

Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?

Shilpa Rao, Saikat Mitra, Harsha Sugur, Vikas Vazhayil, B. Ravi Mohan Rao, Santosh Kumar Annayappa, B. N. Nandeesh, T. C. Yasha, Vani Santosh

20.10.2020 | Original Article | Ausgabe 1/2021

Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas

Dabei Tang, Wenjia Su, Xiaowei Wang, Zhong Chu, Lei Zhang, Jin Zhou, Qingyuan Zhang

24.10.2020 | Case Report | Ausgabe 1/2021

Genetic characterization of an aggressive optic nerve pilocytic glioma

Christopher S. Hong, Greg Fliney, Adeniyi Fisayo, Yi An, Pallavi P. Gopal, Antonio Omuro, Renelle Pointdujour-Lim, E. Zeynep Erson-Omay, S. Bulent Omay

22.11.2020 | Case Report | Ausgabe 1/2021

Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features

Sho Tamai, Yoshiko Nakano, Masashi Kinoshita, Hemragul Sabit, Sumihito Nobusawa, Yasuhito Arai, Natsuko Hama, Yasushi Totoki, Tatsuhiro Shibata, Koichi Ichimura, Mitsutoshi Nakada

18.10.2020 | Case Report | Ausgabe 1/2021

Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination

Soichi Oya, Shunsaku Takayanagi, Hirokazu Takami, Masahiro Indo, Takahisa Yamashita, Nobuhito Saito, Toru Matsui

16.10.2020 | Letter to the Editor | Ausgabe 1/2021

Methylation profiling-based diagnosis of radiologically suspected congenital glioma

Konstantin Bräutigam, Eike Piechowiak, Nedelina Slavova, Beatrice Mosimann, Doron Merkler, Kristof Egervari, Ekkehard Hewer

Aktuelle Ausgaben

Neu im Fachgebiet Chirurgie

06.05.2021 | DDG-Tagung 2021 | Kongressbericht | Nachrichten

Vor- und Nachteile: Welche Geräte lohnen sich?

28.04.2021 | Wechselwirkungen der Krebstherapie | Interview | Ausgabe 5/2021

Sicher therapieren trotz komplexer Medikation

Interview mit Prof. Dr. Ulrich Jaehde, Leiter der Abteilung Klinische Pharmazie am Pharmazeutischen Institut der Rheinischen Friedrich-Wilhelms-Universität Bonn

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise